Evonile Pharma Q2 FY27: First Results After Novartis Exit
Evonile Pharma, formerly Novartis India, posted Q2 FY27 revenue of ₹56.1 crore and an EBITDA loss of ₹31.8 crore as it builds its own field force.
NOVARTIS-INDIA
Vikas Gupta Takes Charge as CEO of Novartis India Limited
Novartis India Ltd has announced the appointment of Vikas Gupta as its Chief Executive Officer, marking a significant leadership transition […]
Novartis India appoints Milan Paleja as vice chairman and MD
Milan Paleja has been appointed as the vice chairman and managing director of Novartis India, a drug firm. The Board […]
